The group is currently targeting further gains in market share and the consolidation of five key specialties in Singapore, including obstetrics & gynaecology (O&G), oncology, health screening, paediatrics and aesthetics via a combination of acquisitions and recruitment.
SINGAPORE (Nov 30): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 78 cents on increasing market share and overseas expansion.
However, SMG’s management highlighted that given the limited industry growth in Singapore, it has to focus on consolidation and gaining market share to grow.
